Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Amylase + lipase + protease 8000unt/30000unt/30000unt tablet |
Is a |
Amylase-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase + protease 8000unt/30000unt/30000unt tablet |
Is a |
Product containing triacylglycerol lipase (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase + protease 8000unt/30000unt/30000unt tablet |
Is a |
Protease-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase + protease 8000unt/30000unt/30000unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Amylase (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase + protease 8000unt/30000unt/30000unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Lipase preparation |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase + protease 8000unt/30000unt/30000unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
proteasi |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase + protease 8000unt/30000unt/30000unt tablet |
Is a |
Product containing amylase and substance with protease mechanism of action and triacylglycerol lipase |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase + protease 8000unt/30000unt/30000unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Lipase |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase + protease 8000unt/30000unt/30000unt tablet |
Has manufactured dose form |
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase + protease 8000unt/30000unt/30000unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Triacylglycerol lipase (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase + protease 8000unt/30000unt/30000unt tablet |
Has manufactured dose form |
Conventional release oral tablet (dose form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase + protease 8000unt/30000unt/30000unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Endopeptidase |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase + protease 8000unt/30000unt/30000unt tablet |
Is a |
Product manufactured as oral dose form (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase + protease 8000unt/30000unt/30000unt tablet |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|